🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
The primary objective of the study was to demonstrate the non-inferiority o...
Status
Completed
Location
Investigational Site Number :8260024
Start Date
2018-10-10
Trial ID
NCT03632720
Treatments Being Tested
The purpose of the study is to provide data on the safety and immunogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00355654
Treatments Being Tested
Primary objective: * To determine the safety and immunogenicity of tetanus...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT02040636
This Phase III, open-label, randomized, parallel-group, active-controlled, ...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-07
Trial ID
NCT03205371
Treatments Being Tested
This study will determine whether participants who receive V419 (PR5I) at 2...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-23
Trial ID
NCT01480258
Treatments Being Tested
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This is a follow-up of Study A3L11 (NCT00404651). Immunogenicity * To des...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00654901